MaaT Pharma CHRONOS Data Reveals Poor aGvHD Survival
LYON, France, April 1, 2026 MaaT Pharma has announced the publication of CHRONOS study data in the peer-reviewed Bone...
Immunotherapy
Advertisement
AKC CHF Partners with All Access for Canine Science TV
RALEIGH, NC, March 30, 2026 The AKC Canine Health Foundation (CHF) has announced a strategic collaboration with the educational...
OS Therapies Advances OST-HER2 Toward Phase 3 Trial
New York, March 27, 2026 OS Therapies has achieved a significant regulatory milestone by securing meetings with multiple global...
Rezpegaldesleukin Shows Strong Phase 2b Results in AD
San Francisco, USA | March 28, 2026 Phase 2b Data Demonstrates Strong Clinical Efficacy Nektar Therapeutics has announced compelling...
Agilent Wins FDA Approval for PD-L1 22C3 Test
Santa Clara, USA – March 26, 2026 Agilent Technologies announced U.S. FDA approval of its PD-L1 IHC 22C3 pharmDx...
Advertisements
Novocure PANOVA-4 Trial Shows Positive Cancer Results
Baar, Switzerland – March 2026 Novocure announced positive topline results from its Phase 2 PANOVA-4 clinical trial evaluating Tumor...
Nektar Therapeutics Reports Phase 2b Rezpegaldesleukin Data
San Francisco, California, USA | March 20, 2026 Nektar Therapeutics has announced that Phase 2b clinical data for rezpegaldesleukin,...
TriSalus Advances Tumor Drug Delivery With PEDD Tech
DENVER, USA – March 18, 2026 TriSalus Life Sciences has announced new preclinical findings demonstrating that its Pressure-Enabled Drug...
AstraZeneca Imfinzi Wins EU Approval for Gastric Cancer
CAMBRIDGE, UK, March 16, 2026 AstraZeneca has received European Commission approval for Imfinzi (durvalumab) as the first and only...
FDA Grants Fast Track to Nipocalimab for Lupus Treatment
SPRING HOUSE, Pa., March 3, 2026 Johnson & Johnson has received U.S. Food and Drug Administration (FDA) Fast Track...
Advertisement
